Emory University

CHICAGO — Pervasive gaps in knowledge and care delivery persist that require urgent attention to reduce sex-based disparities and achieve equity in CV care and outcomes, according to a speaker.

The addition of first-line brentuximab vedotin to chemotherapy reduced risk for relapse compared with standard treatment among pediatric patients with high-risk Hodgkin lymphoma, according to study results.

BOSTON — Optimizing HF therapy is the best way to reduce disease morbidity and mortality and clinicians should consider personalizing and titrating guideline-directed medical therapy based on patient comorbidities, according to a speaker.

More than half of patients had an objective response to first-line nivolumab for locally advanced or metastatic cutaneous squamous cell carcinoma, phase 2 study results published in Cancer showed.

In this video, Byron Williams III, MD, an associate professor of medicine at Emory University School of Medicine, discusses cardiac oscillation in the primary care setting, as well as findings that may require referrals to a cardiologist.

Starting Oct. 13, Emory University will host its 25th Cardiology in Primary Care Conference, a 2.5-day event that will provide information on the outpatient management of cardiac conditions.

CHICAGO — During her talk at the Women in Medicine Summit, Kimberly Manning, MD, FACP, FAAP, discussed the importance of personal reflection and how self-love helps “fan our own flames.”

Prolonged responses to chimeric antigen receptor T-cell therapy for advanced multiple myeloma may depend on the composition of the patient’s post-treatment immune microenvironment, results from a retrospective study showed.

Several hematologists will be honored during this year’s ASH Annual Meeting, scheduled for Dec. 10-13 in New Orleans.

Most patients with non-small cell lung cancer had an adequate antibody response to COVID-19 vaccines, research published in Journal of Clinical Oncology showed.